INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
INMB Key Statistics
Stock Snapshot
As of today, INmune Bio(INMB) shares are valued at $1.58. The company's market cap stands at 41.74M, with a P/E ratio of -0.74.
On 2025-11-11, INmune Bio(INMB) stock traded between a low of $1.57 and a high of $1.69. Shares are currently priced at $1.58, which is +0.6% above the low and -6.5% below the high.
INmune Bio(INMB) shares are trading with a volume of 318.49K, against a daily average of 348.45K.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.53.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.53.
INMB News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...